PORTLAND, Ore. — Virogenomics, Inc. announced today that it has spun-off its autoimmune disease technology into a new company, Artielle ImmunoTherapeutics, Inc. (Artielle), and raised $11 million in venture capital funding for Artielle. Sanderling Ventures of San Mateo, California, led the financing, joined by UV Partners of Salt Lake City, Utah, Tenex Greenhouse of Burlingame, California, and Northwest Technology Ventures of Portland, Oregon
Click here for full story.

Researchers discover how small strokes proactively protect the brain against damage caused by larger strokes; discovery may help in development of “brain-protecting” medications
PORTLAND, Ore. — Collaborative research at Oregon Health & Science University and RS Dow Laboratories at Legacy Health System have uncovered a naturally occurring system in the body that can protect the brain against serious damage during a major stroke.
Click here for full story.

PORTLAND, Ore. — A federal research grant to study a method for preventing and treating stroke has been awarded jointly to Virogenomics Inc., a Portland-based drug discovery company, and Oregon Health & Science University.
Click here for full story.